Drug class
Non-steroidal anti-inflammatory drug (NSAID); flufenamic-acid prodrug
Mechanism of action
Morniflumate is an ester prodrug hydrolysed to flufenamic acid, a fenamate NSAID that inhibits cyclooxygenase-mediated prostaglandin synthesis and reduces inflammation, pain and fever.
General use cases
- Symptomatic treatment of pain and inflammatory conditions, including musculoskeletal and ENT inflammatory disorders, in countries where morniflumate is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
